Yttrium-90-Ibritumomab Tiuxetan and BuCyE High-Dose Chemotherapy Compared with BuCyE Alone As Conditioning Regimen in Patients with B-Cell Non-Hodgkin Lymphoma: IPI Matched Case Control Study At a Single Center

被引：0
|
作者：
Jo, Jae-Cheol
Yoon, Dok Hyun
Kim, Shin
Jang, Seongsoo [2 ]
Park, Chan-Jeoung [2 ]
Chi, Hyun Sook
Park, Chan-Sik [1 ]
Huh, Jooryung [1 ]
Lee, Sang-wook [3 ]
Suh, Cheolwon
机构：
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea
[2] Univ Ulsan, Asan Med Ctr, Dept Lab Med, Seoul, South Korea
[3] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiat Oncol, Seoul, South Korea
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1581 / 1582
页数：2
相关论文
共 50 条
  • [1] Yttrium-90-ibritumomab tiuxetan radioimmunotherapy - A new treatment approach for B-cell non-Hodgkin's lymphoma
    Witzig, TE
    DRUGS OF TODAY, 2004, 40 (02): : 111 - 119
  • [2] Phase II trial of a transplantation regimen of yttrium-90 ibritumomab tiuxetan and high-dose chemotherapy in patients with non-Hodgkin's lymphoma
    Krishnan, Amrita
    Nademanee, Auayporn
    Fung, Henry C.
    Raubitschek, Andrew A.
    Molina, Arturo
    Yamauchi, Dave
    Rodriguez, Roberto
    Spielberger, Ricardo T.
    Falk, Peter
    Palmer, Joycelynne M.
    Forman, Stephen J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (01) : 90 - 95
  • [3] Retreatment with yttrium-90 ibritumomab tiuxetan in patients with B-cell non-Hodgkin's lymphoma
    Shah, Jatin
    Wang, Wenquan
    Harrough, V. Douglas
    Saville, Wayne
    Meredith, Ruby
    Shen, Sui
    Mueh, John
    Li, John
    Jasthy, Sri
    Maggass, Gregory
    Mckay, Charles
    Krumdieck, Richard
    Tharp, Morgan
    Winter, Christine
    Gregory, Stephanie
    Buchholz, William
    Awasthi, Sanjay
    Jacobs, Samuel
    Chung, Harold
    Egner, James
    Lobuglio, Albert F.
    Forero, Andres
    LEUKEMIA & LYMPHOMA, 2007, 48 (09) : 1736 - 1744
  • [4] BEAM or BuCyE high-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin's lymphoma patients
    Kim, J.
    Kim, E.
    Sohn, B.
    Yoon, D.
    Yoo, C.
    Kim, S.
    Lee, D.
    Kim, S.
    Lee, J.
    Suh, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [5] BEAM OR BUCYE HIGH-DOSE CHEMOTHERAPY FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANTATION IN NON-HODGKIN'S LYMPHOMA PATIENTS
    Suh, C.
    Kim, J. E.
    Sohn, B. S.
    Yoon, D. H.
    Lee, D. H.
    Kim, S. W.
    Lee, J. S.
    Kim, S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 643 - 643
  • [6] Yttrium-90 ibritumomab tiuxetan combined with high-dose beam chemotherapy and autologous stem cell transplantation for relapsed/refractory B-cell non-Hodgkin's lymphoma
    Shimabukuro-Vornhagen, A.
    Josting, A.
    Scheid, C.
    Huebel, K.
    Boldt, F.
    Dietlein, M.
    Engert, A.
    Schnell, R.
    ANNALS OF ONCOLOGY, 2008, 19 : 241 - 242
  • [7] Yttrium-90 ibritumomab tiuxetan combined with high-dose BEAM chemotherapy and autologous stem cell transplantation for relapsed/refractory B-cell non-Hodgkin's lymphoma
    Shimabukuro-Vornhagen, A.
    Josting, A.
    Huebel, K.
    Scheid, C.
    Dietlein, M.
    Engert, A.
    Schnell, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [8] Combining yttrium 90-labeled ibritumomab tiuxetan with high-dose chemotherapy and stem cell support in patients with relapsed non-Hodgkin's lymphoma
    Winter, JN
    CLINICAL LYMPHOMA, 2004, 5 : S22 - S26
  • [9] Yttrium-90-ibritumomab tiuxetan (Zevalin) combined with high-dose BEAM chemotherapy and autologous stem cell transplantation for chemo-refractory aggressive non-Hodgkin's lymphoma
    Shimoni, Avichai
    Zwas, S. Tzila
    Oksman, Yakov
    Hardan, Izhar
    Shem-Tov, Noga
    Yerushalmi, Ronit
    Avigdor, Abraham
    Ben-Bassat, Isaac
    Nagler, Arnon
    EXPERIMENTAL HEMATOLOGY, 2007, 35 (04) : 534 - 540
  • [10] Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan as part of a reduced intensity conditioning regimen for allogeneic hematopoietic cell transplantation in patients with advanced non-Hodgkin lymphoma: A phase I/II study
    Bethge, Wolfgimg A.
    Thoralf, Lange
    Bornhaeuser, Martin
    Stadler, Michael
    Uharek, Lutz
    Knop, Stefan
    Von Harsdorf, Stephanie
    Vucinic, Vladdri
    Faul, Christoph
    Vogel, Wichard
    Kanz, Lothar
    Bunjes, Donald
    BLOOD, 2007, 110 (11) : 899A - 899A
12345